NFE2 and essential thrombocythemia: Patients harboring NF-E2 mutations had a higher median hematocrit than non-mutated patients in line with its association with the myeloproliferative phenotype and higher incidence in PV (7.3%) vs. PMF (5.3%) and ET (3.6%) [117].